AKBA

Akebia Ther (AKBA)

US
$ 2.068.42%

Price Chart

Key Statistics

Market Cap
$ 649.23M
P/E Ratio
0.00
Revenue (TTM)
$ 184.91M
Volume
4.54M
52W High
$ 2.90
52W Low
$ 0.80
Dividend Yield
0.00%
Beta
0.88

Technicals

50-Day MA
2.1057
200-Day MA
1.8095
52 Week High
2.9
52 Week Low
0.8

About AKBA

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Employees
181
Headquarters
Cambridge, MA
CEO
Mr. John P. Butler MBA

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
CLIK
Click Holdings Limi...
$ 0.60
112.54
FL
Foot Locker Inc.
$ 23.86
85.39
AYTU
Aytu BioPharma Inc....
$ 2.41
78.52
KDLY
Kindly MD Inc. Comm...
$ 13.06
68.95
LOBO
LOBO EV TECHNOLOGIE...
$ 1.23
41.87

Top Losers

Symbol/Name
LTP
% Chg
IXHL
Incannex Healthcare...
$ 0.33
-52.86
LAZR
Luminar Technologie...
$ 3.94
-15.81
MLGO
MicroAlgo Inc. Ordi...
$ 1.80
-14.29
DKS
Dick's Sporting Goo...
$ 179.75
-14.25
CGBS
Crown LNG Holdings ...
$ 0.09
-13.37